RTI Biologics Announces 2009 Year End, Fourth Quarter Results, Estimates 2010 Revenues and EPS

February 9, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading processor of orthopedic and other biologic implants, reported operating results for the fourth quarter and full year ending Dec. 31, 2009.

Twitter
LinkedIn
Facebook
Email
Print

Earnings